<?xml version="1.0" encoding="UTF-8"?>
<ref id="B109-pharmaceutics-12-00171">
 <label>109.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Al-Obaidi</surname>
    <given-names>M.M.J.</given-names>
   </name>
   <name>
    <surname>Bahadoran</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>S.M.</given-names>
   </name>
   <name>
    <surname>Manikam</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Raju</surname>
    <given-names>C.S.</given-names>
   </name>
   <name>
    <surname>Sekaran</surname>
    <given-names>S.D.</given-names>
   </name>
  </person-group>
  <article-title>Disruption of the blood brain barrier is vital property of neurotropic viral infection of the central nervous system</article-title>
  <source>Acta Virol.</source>
  <year>2018</year>
  <volume>62</volume>
  <fpage>16</fpage>
  <lpage>27</lpage>
  <pub-id pub-id-type="doi">10.4149/av_2018_102</pub-id>
  <pub-id pub-id-type="pmid">29521099</pub-id>
 </element-citation>
</ref>
